Literature DB >> 32119644

Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.

Jay Lubow1, Maria C Virgilio2, Madeline Merlino3, David R Collins1, Michael Mashiba4, Brian G Peterson5, Zana Lukic3, Mark M Painter4, Francisco Gomez-Rivera4, Valeri Terry3, Gretchen Zimmerman4, Kathleen L Collins2,3,4.   

Abstract

HIV-1 Vpr is necessary for maximal HIV infection and spread in macrophages. Evolutionary conservation of Vpr suggests an important yet poorly understood role for macrophages in HIV pathogenesis. Vpr counteracts a previously unknown macrophage-specific restriction factor that targets and reduces the expression of HIV Env. Here, we report that the macrophage mannose receptor (MR), is a restriction factor targeting Env in primary human monocyte-derived macrophages. Vpr acts synergistically with HIV Nef to target distinct stages of the MR biosynthetic pathway and dramatically reduce MR expression. Silencing MR or deleting mannose residues on Env rescues Env expression in HIV-1-infected macrophages lacking Vpr. However, we also show that disrupting interactions between Env and MR reduces initial infection of macrophages by cell-free virus. Together these results reveal a Vpr-Nef-Env axis that hijacks a host mannose-MR response system to facilitate infection while evading MR's normal role, which is to trap and destroy mannose-expressing pathogens.
© 2020, Lubow et al.

Entities:  

Keywords:  HIV; Nef; Vpr; human; immunology; infectious disease; inflammation; macrophages; mannose receptor; microbiology; restriction factor

Mesh:

Substances:

Year:  2020        PMID: 32119644      PMCID: PMC7051176          DOI: 10.7554/eLife.51035

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  84 in total

1.  The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose.

Authors:  Eamon P McGreal; Marcela Rosas; Gordon D Brown; Susanne Zamze; Simon Y C Wong; Siamon Gordon; Luisa Martinez-Pomares; Philip R Taylor
Journal:  Glycobiology       Date:  2006-01-19       Impact factor: 4.313

2.  Direct interaction between XRCC1 and UNG2 facilitates rapid repair of uracil in DNA by XRCC1 complexes.

Authors:  Mansour Akbari; Karin Solvang-Garten; Audun Hanssen-Bauer; Nora Valeska Lieske; Henrik Sahlin Pettersen; Grete Klippenvåg Pettersen; David M Wilson; Hans E Krokan; Marit Otterlei
Journal:  DNA Repair (Amst)       Date:  2010-05-13

3.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.

Authors:  Bärbel Schröfelbauer; Qin Yu; Samantha G Zeitlin; Nathaniel R Landau
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.

Authors:  Chad M McCall; Paula L Miliani de Marval; Paul D Chastain; Sarah C Jackson; Yizhou J He; Yojiro Kotake; Jeanette Gowen Cook; Yue Xiong
Journal:  Mol Cell Biol       Date:  2008-07-07       Impact factor: 4.272

6.  Persistent productive HIV-1 infection of a CD4- human fetal thymocyte line.

Authors:  W C Hatch; K E Tanaka; T Calvelli; W K Rashbaum; Y Kress; W D Lyman
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

7.  Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.

Authors:  A Trkola; M Purtscher; T Muster; C Ballaun; A Buchacher; N Sullivan; K Srinivasan; J Sodroski; J P Moore; H Katinger
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.

Authors:  R Collman; J W Balliet; S A Gregory; H Friedman; D L Kolson; N Nathanson; A Srinivasan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.

Authors:  David R Collins; Jay Lubow; Zana Lukic; Michael Mashiba; Kathleen L Collins
Journal:  PLoS Pathog       Date:  2015-07-17       Impact factor: 6.823

Review 10.  Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.

Authors:  Jan Balzarini
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

View more
  6 in total

1.  The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter.

Authors:  Sandra Kao; Eri Miyagi; Rosa Mallorson; Hideki Saito; Sayaka Sukegawa; Abhik Mukherji; Allyson Mateja; Damien Ferhadian; Helena Fabryova; Kathleen Clouse; Klaus Strebel
Journal:  J Virol       Date:  2022-06-29       Impact factor: 6.549

2.  Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

Authors:  Jérémy A Ferreira Barbosa; Samantha Sparapani; Jonathan Boulais; Robert Lodge; Éric A Cohen
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 3.  Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis.

Authors:  Jay Lubow; Kathleen L Collins
Journal:  Viruses       Date:  2020-07-27       Impact factor: 5.048

Review 4.  Retroviral Restriction Factors and Their Viral Targets: Restriction Strategies and Evolutionary Adaptations.

Authors:  Guney Boso; Christine A Kozak
Journal:  Microorganisms       Date:  2020-12-11

5.  Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Authors:  Li Zhao; Shumei Wang; Meng Xu; Yang He; Xiaowei Zhang; Ying Xiong; Hong Sun; Haibo Ding; Wenqing Geng; Hong Shang; Guoxin Liang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

Review 6.  Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.

Authors:  Isabel Pagani; Pietro Demela; Silvia Ghezzi; Elisa Vicenzi; Massimo Pizzato; Guido Poli
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.